Founded in 2009, Cowin has built a business network covering China and the United States. Now we have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.
A preferred institutional investor by first-class high-tech entrepreneurs, we partner with the Innovation Fund Management Center of the Ministry of Science and Technology, SDIC Chuanghe, CRRC Times, as well as local government guiding funds.
In TMT and Healthcare, Cowin has an sophisticated investment team with strong industry experiences and the ability to integrate resources.
Total assets under management (both RMB and USD) is near 5 billion yuan, consisting of seed funds, VC funds and PE funds.
Cowin has invested in more than 80 outstanding start-ups, 30 of which, such as Tongcheng, InnoLight, Taimei and GeneCast, have grown into industry unicorns.
10 companies, including Eastsoft, , NewVision, ALAE, Diasc, Tongcheng,Jia.com and InnoLight, were successfully listed.
We look for outstanding entrepreneurs and help to accelerate the growth of start-ups.